Project Details
Project Description
| Status | Active |
|---|---|
| Effective start/end date | 18/08/25 → 17/08/30 |
Clinical Trial Phase
- Phase III (a & b)
exPDite-2: A Phase 3 Study to Assess the Efficacy and Safety of Midbrain Dopaminergic Neuronal Cell Therapy (Bemdaneprocel) for Participants With Parkinson's Disease
- Vijiaratnam, Nirosen (Primary Chief Investigator (PCI))
Project: Research